Cannabis is one of the most widely used recreational drugs worldwide. It comes in many variations that have been used both for medicinal purposes e.g. in the treatment or management of various diseases, as well for recreational purposes to achieve a ‘high’.
Recently, Canada became the first major western country to legalise marijuana/cannabis for recreational and medicinal usage and cultivation.
The United Kingdom has now made exceptions for the use of medicinal cannabis in the treatment of severe epilepsy, chemotherapy-related illness and multiple sclerosis (MS).
Sativa Investments PLC invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical cannabis. Their investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing.